PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, informs its shareholders that the annual general meeting (AGM) of May 11, […]
Author: Ken Dropiewski
Impulse Dynamics Announces First Implants of Optimizer Smart Mini
Company Is Committed to Innovation for Patients Living With Heart Failure MARLTON, N.J., May 10, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is announcing today the first implants of its newly launched Optimizer® Smart Mini, […]
Filterlex Medical Successfully Completes First-In-Human Study for CAPTIS® Full-Body Embolic Protection Device
Cardiovascular study results to be presented by Prof. Ran Kornowski, Director of the Cardiology Center, Rabin Medical Center at the EuroPCR 2022 conference in May CAESAREA, Israel, May 10, 2022 /PRNewswire/ — Filterlex Medical Ltd., a cardiovascular medical device startup, announced today that it has completed its CAPTIS First-In-Human (FIH) study. Study results […]
Magneto Thrombectomy Solutions Announces Successful First-in-Human Results for Treatment of Pulmonary Embolism (PE)
– The eTrieve™ catheter for removing blood clots, based on electric fields, met safety and feasibility endpoints – Data, showing significant reduction RV/LV ratio and alleviation of PE associated symptoms, presented at Biomed Israel 2022 OR YEHUDA, Israel, May 10, 2022 /PRNewswire/ — Magneto Thrombectomy Solutions (Magneto), a medical devices company developing innovative thrombectomy solutions for the […]
ARTRYA SIGNS FIRST U.S. HOSPITAL CLINICAL PARTNERSHIP WITH HUNTSVILLE HEART CENTER
Initial agreement includes comparison study of patient cardiac CT scans read by experts to those read by AI-based technology HUNTSVILLE, Ala., May 10, 2022 /PRNewswire/ — Artrya Ltd, creator of the AI-based cardiac software solution Artrya Salix, today announced its first U.S. clinical partnership with Alabama-based Huntsville Heart Center, Inc, a national leader […]
OMRON Healthcare Unveils Long-term Corporate Vision, “Going for ZERO, Preventive Care for Health of Society”
– Aiming to Realize 3 Zeros: “Zero Cerebrovascular and Cardiovascular Events,” “Zero Aggravation of Respiratory Diseases” and “Zero Restrictions on Daily Activities Due to Chronic Pain” – KYOTO, Japan, May 10, 2022 /PRNewswire/ — In March 2022, OMRON Group announced a new long-term vision, “Shaping the Future 2030” (hereafter referred to as SF2030). In its commitment […]
MT2020+ Launches the #BEFASTchallenge to Raise Public Stroke Awareness
The viral social media effort will illustrate stroke symptom recognition, the timeliness to seek help and raise money WASHINGTON, May 10, 2022 /PRNewswire/ — Mission Thrombectomy 2020+ (MT2020+), a global initiative of the Society of Vascular and Interventional Neurology (SVIN), has created a worldwide dance challenge to raise awareness of stroke symptoms and the […]
Access Vascular Inc. Named 2022 MedTech Breakthrough Award Winner
Access Vascular’s transformational biomaterial catheters named “Best New Technology Solution” for ability to dramatically improve vascular access medical and economic outcomes BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) — Access Vascular, Inc. (AVI) today announced it has been named “Best New Technology Solution – Drug Delivery” in the 2022 MedTech Breakthrough […]
Shockwave Medical Reports First Quarter 2022 Financial Results
SANTA CLARA, Calif., May 09, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months ended March 31, 2022. Recent Highlights Recognized revenue of $93.6 million […]
Stereotaxis Reports 2022 First Quarter Financial Results
ST. LOUIS, May 10, 2022 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the first quarter ended March 31, 2022. “Stereotaxis demonstrated continued progress on capital adoption despite a challenging macro environment,” said David Fischel, Chairman […]



